Management of psoriatic arthritis: Turkish League Against Rheumatism (TLAR) expert opinions

Simple item page
dc.contributor.authorNas K.
dc.contributor.authorKiliç E.
dc.contributor.authorÇevik R.
dc.contributor.authorBodur H.
dc.contributor.authorAtaman Ş.
dc.contributor.authorAyhan F.
dc.contributor.authorAkgül Ö.
dc.contributor.authorAkinci A.
dc.contributor.authorAltay Z.
dc.contributor.authorÇapkın E.
dc.contributor.authorDağli A.Z.
dc.contributor.authorDuruöz T.
dc.contributor.authorGürer G.
dc.contributor.authorGöğüş F.
dc.contributor.authorGarip Y.
dc.contributor.authorKaçar C.
dc.contributor.authorKamanli A.
dc.contributor.authorKaptanoğlu E.
dc.contributor.authorKaya T.
dc.contributor.authorKocabaş H.
dc.contributor.authorÖzdemirel E.A.
dc.contributor.authorÖzel S.
dc.contributor.authorSezer İ.
dc.contributor.authorSunar İ.
dc.contributor.authorYilmaz G.
dc.date.accessioned2024-07-22T08:09:44Z
dc.date.available2024-07-22T08:09:44Z
dc.date.issued2018
dc.description.abstractObjectives: This study aims to establish the first national treatment recommendations by the Turkish League Against Rheumatism (TLAR) for psoriatic arthritis (PsA) based on the current evidence. Materials and methods: A systematic literature review was performed regarding the management of PsA. The TLAR expert committee consisted of 13 rheumatologists and 12 physical medicine and rehabilitation specialists experienced in the treatment and care of patients with PsA from 22 centers. The TLAR recommendations were built on those of European League Against Rheumatism (EULAR) 2015. Levels of evidence and agreement were determined. Results: Recommendations included five overarching principles and 13 recommendations covering therapies for PsA, particularly focusing on musculoskeletal involvement. Level of agreement was greater than eight for each item. Conclusion: This is the first paper that summarizes the recommendations of TLAR as regards the treatment of PsA. We believe that this paper provides Turkish physicians dealing with PsA patients a practical guide in their routine clinical practice. © 2018 Turkish League Against Rheumatism. All rights reserved.
dc.identifier.DOI-ID10.5606/ArchRheumatol.2018.6946
dc.identifier.issn21485046
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14945
dc.language.isoEnglish
dc.publisherTurkish League Against Rheumatism (TLAR)
dc.rightsAll Open Access; Gold Open Access
dc.subjectabatacept
dc.subjectapremilast
dc.subjectC reactive protein
dc.subjectglucocorticoid
dc.subjectinterleukin 12
dc.subjectinterleukin 17
dc.subjectinterleukin 23
dc.subjectixekizumab
dc.subjectlive vaccine
dc.subjectmethotrexate
dc.subjectnonsteroid antiinflammatory agent
dc.subjectsecukinumab
dc.subjecttofacitinib
dc.subjecttumor necrosis factor
dc.subjectustekinumab
dc.subjectArticle
dc.subjectaxial disease
dc.subjectcomorbidity
dc.subjectcomputer assisted tomography
dc.subjectcost benefit analysis
dc.subjectdactylitis
dc.subjectdisability
dc.subjectdisease activity
dc.subjectenthesitis
dc.subjectfollow up
dc.subjectHealth Assessment Questionnaire
dc.subjecthuman
dc.subjectinflammation
dc.subjectlifestyle modification
dc.subjectmusculoskeletal disease
dc.subjectnuclear magnetic resonance imaging
dc.subjectoccupational therapy
dc.subjectoutcome assessment
dc.subjectpatient care
dc.subjectphysical medicine
dc.subjectphysiotherapy
dc.subjectpsoriasis
dc.subjectpsoriatic arthritis
dc.subjectquality of life
dc.subjectrandomized controlled trial (topic)
dc.subjectrheumatic disease
dc.subjectrheumatologist
dc.subjectsafety
dc.subjectshared decision making
dc.subjectsystematic review
dc.subjectvisual analog scale
dc.titleManagement of psoriatic arthritis: Turkish League Against Rheumatism (TLAR) expert opinions
dc.typeArticle

Files

Collections

Scopus Koleksiyonu